Evidence map›Paper›PMID 31250250›Full record

ReviewCurrent treatment options in oncology2019

Cardiac Tumors: Clinical Presentation, Diagnosis, and Management.

Timothy J Poterucha, Jonathan Kochav, Daniel S O'Connor, Gregg F Rosner

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current treatment options in oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 130 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
130citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

130 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Cardiac metastasis in uterine cervical cancer : A systematic review and case study.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2025
    Pooled it
  2. Pooled it
  3. Article
  4. Arrhythmic risk in ventricular cardiac tumors: A comparative imaging and clinical analysis.American heart journal plus : cardiology research and practice · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Advancing cardiac tumor diagnosis: evaluatingAmerican journal of cardiovascular disease · 2026
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

70 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Timothy J PoteruchaDepartment of Medicine, Division of Cardiology, Columbia University Medical Center, 161 Fort Washington Avenue, Suite 6-647, New York, NY, 10032, USA.
Jonathan KochavDepartment of Medicine, Division of Cardiology, Columbia University Medical Center, 161 Fort Washington Avenue, Suite 6-647, New York, NY, 10032, USA.
Daniel S O'ConnorDepartment of Medicine, Division of Cardiology, Columbia University Medical Center, 161 Fort Washington Avenue, Suite 6-647, New York, NY, 10032, USA.
Gregg F RosnerDepartment of Medicine, Division of Cardiology, Columbia University Medical Center, 161 Fort Washington Avenue, Suite 6-647, New York, NY, 10032, USA. gfr2107@cumc.columbia.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

opinion statementCardiac masses and tumors are a heterogenous group of disorders and include primary tumors (both benign and malignant), metastatic disease, and numerous masquerades such as thrombus. Clinical presentation ranges from incidental discovery on imaging tests ordered for other reasons to life-threatening presentations such as cardiac tamponade, arrhythmia, obstruction, and systemic embolization. Of the available imaging modalities, cardiac MRI is generally the most useful for assessment and helps to delineate the relevant anatomy. Due to the technical difficulties and risk of biopsy of cardiac masses, a presumptive diagnosis is typically made using imaging techniques with surgery serving both a diagnostic and curative role. Because these conditions can vary widely in their management, we recommend early involvement of a multidisciplinary group which should include a cardiologist, cardiac surgeon, and oncologist.

Indexed as

BiopsyCombined Modality TherapyDiagnosis, DifferentialDiagnostic ImagingDisease ManagementHeart NeoplasmsHumansIncidenceNeoplasm GradingNeoplasm StagingSymptom AssessmentTreatment OutcomeCardiac massCardiac tumorMyxomaRhabdomyomaRhabdomyosarcoma

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.